3 Top Stocks for Obamacare Lovers
Love Obamacare? These stocks are right up your alley.
3 Little-Known Biotechs Working On Potential Blockbusters
These three biotechs have promising drugs in their pipelines that address billion dollar drug markets.
5 Freakishly Expensive Cancer Drugs
Prices for cancer medications are soaring.
Is It Time for GlaxoSmithKline plc to Change Management?
GlaxoSmithKline's share price has stagnated under CEO Andrew Witty. Is it time for a change?
Is This The Biggest Threat to Isis Pharmaceuticals Stock?
Isis Pharmaceuticals has garnered a massive premium based on the potential of its antisense drug pipeline. With numerous companies entering the rare disease field, though, Isis' drugs might face stiff competition. So are investors being overly optimistic?